LLY

735.02

+1.26%↑

JNJ

177.01

-0.32%↓

ABBV

210.01

+0.49%↑

UNH

330.34

+3.53%↑

NVO

53.02

-2.79%↓

LLY

735.02

+1.26%↑

JNJ

177.01

-0.32%↓

ABBV

210.01

+0.49%↑

UNH

330.34

+3.53%↑

NVO

53.02

-2.79%↓

LLY

735.02

+1.26%↑

JNJ

177.01

-0.32%↓

ABBV

210.01

+0.49%↑

UNH

330.34

+3.53%↑

NVO

53.02

-2.79%↓

LLY

735.02

+1.26%↑

JNJ

177.01

-0.32%↓

ABBV

210.01

+0.49%↑

UNH

330.34

+3.53%↑

NVO

53.02

-2.79%↓

LLY

735.02

+1.26%↑

JNJ

177.01

-0.32%↓

ABBV

210.01

+0.49%↑

UNH

330.34

+3.53%↑

NVO

53.02

-2.79%↓

Search

Alcon Inc

Deschisă

SectorSănătate

79.57 -0.1

Rezumat

Modificarea prețului

24h

Curent

Minim

79.24

Maxim

80.04

Indicatori cheie

By Trading Economics

Venit

-167M

183M

Vânzări

123M

2.6B

P/E

Medie Sector

36.949

35.733

Randament dividend

0.42

Marjă de profit

7.058

Angajați

25,000

EBITDA

-213M

250M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+23.1% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.42%

3.13%

Următoarele câștiguri

11 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-4.3B

40B

Deschiderea anterioară

79.67

Închiderea anterioară

79.57

Sentimentul știrilor

By Acuity

10%

90%

13 / 371 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Alcon Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

2 sept. 2025, 23:07 UTC

Achiziții, Fuziuni, Preluări

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

20 aug. 2025, 17:21 UTC

Câștiguri
Principalele dinamici ale pieței

Alcon Shares Sink After Cut to Fiscal Year Sales Guidance

20 aug. 2025, 08:46 UTC

Câștiguri
Principalele dinamici ale pieței

Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit

5 aug. 2025, 10:10 UTC

Achiziții, Fuziuni, Preluări

Alcon to Buy Staar Surgical for $1.5 Billion

14 mai 2025, 15:56 UTC

Câștiguri
Principalele dinamici ale pieței

Alcon Shares Fall After Lowering 2025 Outlook

26 mar. 2025, 21:22 UTC

Achiziții, Fuziuni, Preluări

Alcon Buys Majority Stake in Aurion to Advance Eye Disease Treatment

20 aug. 2025, 17:06 UTC

Câștiguri
Principalele dinamici ale pieței

Alcon Shares Sink After Cut to FY Sales Guidance

19 aug. 2025, 20:32 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Alcon Cuts 2025 View To Sales $10.3B-$10.4B >ALC.EB

19 aug. 2025, 20:31 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Alcon 2Q EPS 35c >ALC.EB

19 aug. 2025, 20:30 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Alcon 2Q Sales $2.58B >ALC.EB

19 aug. 2025, 20:30 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr And Announced Acquisition Of STAAR Surgical >ALC

8 aug. 2025, 13:40 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Staar Surgical's Top Holder Questions Deal -- Market Talk

5 aug. 2025, 05:07 UTC

Achiziții, Fuziuni, Preluări

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5 aug. 2025, 05:07 UTC

Achiziții, Fuziuni, Preluări

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5 aug. 2025, 05:07 UTC

Achiziții, Fuziuni, Preluări

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5 aug. 2025, 05:07 UTC

Achiziții, Fuziuni, Preluări

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5 aug. 2025, 05:01 UTC

Achiziții, Fuziuni, Preluări

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

7 iul. 2025, 12:00 UTC

Achiziții, Fuziuni, Preluări

Alcon To Acquire LumiThera And Its Photobiomodulation Device For The Treatment Of Early And Intermediate Dry Age-Related Macular Degeneration (AMD) >ALC

30 mai 2025, 06:32 UTC

Market Talk
Câștiguri

Alcon's First FDA Approval Since Listing Is Positive, But Expected -- Market Talk

22 mai 2025, 20:46 UTC

Achiziții, Fuziuni, Preluări

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

13 mai 2025, 20:32 UTC

Câștiguri

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13 mai 2025, 20:31 UTC

Câștiguri

Alcon 1Q Sales $2.45B >ALC.EB

13 mai 2025, 20:30 UTC

Câștiguri

Alcon 1Q Rev $2.47B >ALC.EB

13 mai 2025, 20:30 UTC

Câștiguri

Alcon 1Q EPS 70c >ALC.EB

8 apr. 2025, 08:20 UTC

Market Talk

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

26 mar. 2025, 21:55 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Alcon Deal for Aurion Follows 2022 Investment, 2024 Lawsuit -- Market Talk

26 mar. 2025, 20:33 UTC

Achiziții, Fuziuni, Preluări

Aurion Board Appoints Arnaud Lacoste as CEO of Aurion

26 mar. 2025, 20:32 UTC

Achiziții, Fuziuni, Preluări

Alcon: Aurion Will Operate as a Separate Company With Full Support From Alcon to Advance Its Clinical-Stage Allogeneic Cell Therapy Asset

26 mar. 2025, 20:32 UTC

Achiziții, Fuziuni, Preluări

Leverages Alcon's Global Scale With Aurion's Cell Therapy Expertise to Accelerate U.S. Phase 3 Development in Fall of 2025 >ALC.EB

26 mar. 2025, 20:31 UTC

Achiziții, Fuziuni, Preluări

Alcon Acquires Interest in Aurion to Advance Innovative Cell Therapy for Corneal Endothelial Disease >ALC.EB

Comparație

Modificare preț

Alcon Inc Așteptări

Obiectiv de preț

By TipRanks

23.1% sus

Prognoză pe 12 luni

Medie 98.69 USD  23.1%

Maxim 119.067 USD

Minim 77.53 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAlcon Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

18 ratings

13

Cumpărare

5

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

95.77 / 97.61Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Strong Bullish Evidence

Sentiment

By Acuity

13 / 371 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat